Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16799 publications
Integrating Network Pharmacology to Investigate Cinnamaldehyde's Protective Effect Against Oxaliplatin-induced Neurotoxicity.
Journal: Journal of visualized experiments : JoVE
Published: December 15, 2025
BE screen reveals METTL3 S2 dephosphorylation sensitizes gastric cancer cells to oxaliplatin by interfering METTL3-eIF3H interaction.
Journal: Science advances
Published: December 12, 2025
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage.
Journal: Science advances
Published: December 12, 2025
Multi-pathway therapeutics in colorectal cancer: Targeting EMT, CSCs, and non-apoptotic cell death for drug resistance reversal.
Journal: Journal of drug targeting
Published: December 10, 2025
Cost-effectiveness of sugemalimab plus chemotherapy as first-line therapy in advanced gastric cancer and gastroesophageal junction cancer.
Journal: Annals of medicine
Published: December 10, 2025
An Enhanced Cancer Immunogenic Cell Death Strategy: Fibrate-Oxaliplatin(IV) Conjugates with Modulating Tumor Immune Microenvironment.
Journal: Journal of medicinal chemistry
Published: December 09, 2025
Fucoidan Alleviates Chemotherapy-Induced Peripheral Neuropathy via Activating the Gas6/MerTK Signaling Pathway to Reduce Neuroinflammation.
Journal: Journal of agricultural and food chemistry
Published: December 06, 2025
Effect of ART1 on the efficacy of oxaliplatin in colorectal cancer under high-cholesterol conditions.
Journal: Histology and histopathology
Published: December 05, 2025
Alectinib and SALL4-Targeted Fatty Acid Oxidation: A Strategy to Combat Oxaliplatin Resistance in Gastric Cancer.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: December 04, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 04, 2025
A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.
Journal: Future oncology (London, England)
Published: December 03, 2025
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning.
Journal: JCO clinical cancer informatics
Published: December 02, 2025
Last Updated: 01/07/2026